Aranesp 20 mcg — Amgen (Darbepoetin alfa)
Aranesp is a high-quality pharmaceutical solution designed for hematopoietic support. Specifically formulated for precise administration, this product is utilized for its ability to stimulate the production of red blood cells through targeted biological mechanisms. Whether for clinical or specialized use, Aranesp provides a reliable solution for erythropoietic stimulation.
Specifications
| Active Substance | Erythropoietin (Darbepoetin alfa) |
| Form | 1 syringe x 0.5 ml x 20 mcg |
| Manufacturer | Amgen |
Product Overview & Mechanism of Action
Aranesp is engineered with a unique molecular structure that differentiates it from standard recombinant human erythropoietin (rhEPO). The active component, Darbepoetin alfa, is designed to stimulate erythropoiesis (the production of red blood cells) via the same biological pathways as endogenous erythropoietin.
The scientific distinction lies in its molecular composition. Unlike standard rhEPO, Darbepoetin alfa contains five N-linked carbohydrate chains. This increased carbohydrate content results in a significantly longer half-life within the body, allowing for greater in vivo activity and sustained effectiveness.
While the molecular structure is modified for extended activity, the substance retains a highly specific affinity for the erythropoietin receptor. This makes it an essential tool for stimulating red blood cell production with precision. This product is suitable for professional environments where high-standard pharmaceutical accuracy is required.
- Targeted Action: Stimulates red blood cell production via erythropoietic mechanisms.
- Advanced Formulation: Enhanced molecular structure for extended half-life.
- Precision Dosing: Provided in pre-filled syringes for accurate administration.
- Quality Assured: Manufactured by Amgen, a leader in pharmaceutical excellence.